An activator of mTOR inhibits oxLDL-induced autophagy and apoptosis in vascular endothelial cells and restricts atherosclerosis in apolipoprotein E-/- mice

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Peng, Nan ^a   Meng, Ning ^a,b   Wang, Shengqing ^a   Zhao, Fei ^a   Zhao, Jing ^a   Su, Le ^a   Zhang, Shangli ^a   Zhang, Yun ^c   Zhao, Baoxiang ^a   Miao, Junying ^a,c  

^a SHANDONG UNIVERSITY   (China)

^b UNIVERSITY OF JINAN   (China)

^c SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3-BENZYL-5-((2-NITROPHENOXY)METHYL)DIHYDROFURAN-2(3H)-ONE; APOLIPOPROTEIN E; GAMMA BUTYROLACTONE; LOW DENSITY LIPOPROTEIN; MTOR PROTEIN, MOUSE; OXIDIZED LOW DENSITY LIPOPROTEIN; TARGET OF RAPAMYCIN KINASE;

ANALOGS AND DERIVATIVES; ANIMAL; ATHEROSCLEROSIS; AUTOPHAGY; C57BL MOUSE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; ENDOTHELIUM CELL; GENETICS; KNOCKOUT MOUSE; MALE; METABOLISM; MOUSE; TREATMENT OUTCOME;

4-BUTYROLACTONE; ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; AUTOPHAGY; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; LIPOPROTEINS, LDL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; TOR SERINE-THREONINE KINASES; TREATMENT OUTCOME;

EID: 84903736703     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep05519     Document Type: Article

References (40)

1. Rioufol, G. et al. Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study. Circulation 106, 804-808 (2002).
2. Simionescu, M. & Antohe, F. Functional ultrastructure of the vascular endothelium: changes in various pathologies. Handb. Exp. Pharmacol. 176 Pt 1, 41-69 (2006).
3. Sima, A. V., Stancu, C. S. & Simionescu, M. Vascular endothelium in atherosclerosis. Cell. Tissue. Res. 335, 191-203 (2009).
4. Rajendran, P. et al. The Vascular Endothelium and Human Diseases. Int. J. Biol. Sci. 9, 1057-1069 (2013).
5. Weichhart, T. Mammalian target of rapamycin: a signaling kinase for every aspect of cellular life. Methods. Mol. Biol. 821, 1-14 (2012).
6. Laplante, M. & Sabatini, D. M.mTORsignaling in growth control and disease. Cell 149, 274-293 (2012).
7. Khan, S. et al. Rapamycin confers preconditioning-like protection against isc (Pubitemid 44080210)
8. Niccoli, G. et al. Impact of gender on clinical outcomes after mTOR-inhibitor drug-eluting stent implantation in patients with first manifestation of ischaemic heart disease. Eur. J. Prev. Cardiol. 19, 914-926 (2012).
9. Santulli, G. & Totary-Jain,H. Tailoring mTOR-based therapy: molecular evidence and clinical challenges. Pharmacogenomics 14, 1517-1526 (2013).
10. Elloso, M. M. et al. Protective effect of the immunosuppressant sirolimus against aortic atherosclerosis in apo E-deficient mice. Am. J. Transplant. 3, 562-569 (2003). (Pubitemid 36612839)
11. Verheye, S. et al. Selective clearance of macrophages in atherosclerotic plaques by autophagy. J. Am. Coll. Cardiol. 49, 706-715 (2007). (Pubitemid 46205042)
12. Martinet, W. et al. Drug-induced macrophage autophagy in atherosclerosis: for better or worse? Basic. Res. Cardiol. 108, 321 (2013).
13. Camici, G. G. et al. Rapamycin promotes arterial thrombosis in vivo: implications for everolimus and zotarolimus eluting stents. Eur. Heart. J. 31, 236-242 (2010).
14. Miriuka, S. G. et al. mTOR inhibition induces endothelial progenitor cell death. Am. J. Transplant. 6, 2069-2079 (2006). (Pubitemid 44199541)
15. Chong, Z. Z., Shang, Y. C. & Maiese, K. Cardiovascular disease and mTOR signaling. Trends. Cardiovasc. Med. 21, 151-155 (2011).
16. Humar, R., Kiefer, F. N., Berns, H., Resink, T. J. & Battegay, E. J. Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR)- dependent signaling. FASEB. J. 16, 771-780 (2002). (Pubitemid 34615125)
17. Wang, W. et al. Both senescence and apoptosis induced by deprivation of growth factors were inhibited by a novel butyrolactone derivative through depressing integrin beta4 in vascular endothelial cells. Endothelium 14, 325-332 (2007).
18. Meng, N. et al. A novel butyrolactone derivative inhibited smooth muscle cell migration and proliferation and maintained endothelial cell functions through selectively affecting Na, K-ATPase activity and mitochondria membrane potential during in vitro angiogenesis. J. Cell. Biochem. 104, 2123-2130 (2008).
19. Huang, B. et al. Protective effects of a synthesized butyrolactone derivative against chloroquine-induced autophagic vesicle accumulation and the disturbance of mitochondrial membrane potential and Na1,K1-ATPase activity in vascular endothelial cells. Chem. Res. Toxicol. 22, 471-475 (2009).
20. Meng, N. et al. Abutyrolactone derivative suppressed lipopolysaccharide- induced autophagic injury through inhibiting the autoregulatory loop of p8 and p53 in vascular endothelial cells. Int. J. Biochem. Cell. Bio. 44, 311-319 (2012).
21. Yang, S. et al. Butyrolactone derivative 3-benzyl-5-((2-nitrophenoxy) methyl)- dihydrofuran-2(3H)-one protects against amyloid-beta peptides-induced cytotoxicity in PC12 cells. J. Alzheimers. Dis. 28, 345-356 (2012).
22. Ge,D. et al. Identification of a novelmTORactivator and discovery of a competing endogenous RNA regulating autophagy in vascular endothelial cells. Autophagy 10, 957-971 (2014).
23. Mercer, C. A., Kaliappan, A. & Dennis, P. B. A novel, human Atg13 binding protein, Atg101, interacts with ULK1 and is essential for macroautophagy. Autophagy 5, 649-662 (2009).
24. Hosokawa, N. et al. Nutrient-dependent mTORC1 association with the ULK1- Atg13-FIP200 complex required for autophagy. Mol. Biol. Cell. 20, 1981-1991 (2009).
25. Johnson, S. C., Rabinovitch, P. S. & Kaeberlein, M. mTOR is a key modulator of ageing and age-related disease. Nature 493, 338-345 (2013).
26. Easton, J. B. & Houghton, P. J. Therapeutic potential of target of rapamycin inhibitors. Expert. Opin. Ther. Targets. 8, 551-564 (2004). (Pubitemid 40028366)
27. Sciarretta, S., Volpe, M. & Sadoshima, J. Mammalian target of rapamycin signaling in cardiac physiology and disease. Circ. Res. 114, 549-564 (2014).
28. Wang, X. et al. Knockdown of mTOR by lentivirusmediated RNA interference suppresses atherosclerosis and stabilizes plaques via a decrease of macrophages by autophagy in apolipoprotein Edeficient mice. Int. J. Mol. Med. 32, 1215-1221 (2013).
29. Lemaitre, V., Dabo, A. J. & D'Armiento, J. Cigarette smoke components induce matrix metalloproteinase-1 in aortic endothelial cells through inhibition of mTOR signaling. Toxicol. Sci. 123, 542-549 (2011).
30. Yentrapalli, R. et al. The PI3K/Akt/mTOR pathway is implicated in the premature senescence of primary human endothelial cells exposed to chronic radiation. PloS one 8, e70024 (2013).
31. Pendyala, L. K. et al. The first-generation drug-eluting stents and coronary endothelial dysfunction. JACC. Cardiovasc. Interv. 2, 1169-1177 (2009).
32. Zabirnyk, O., Liu,W., Khalil, S., Sharma, A. & Phang, J. M. Oxidized low-density lipoproteins upregulate proline oxidase to initiate ROS-dependent autophagy. Carcinogenesis 31, 446-454 (2010).
33. Yu,M., Kang, X., Xue, H. & Yin, H. Toll-like receptor 4 is up-regulated by mTOR activation during THP-1 macrophage foam cells formation. Acta. Biochim. Biophys. Sin. 43, 940-947 (2011).
34. Ding, Z. et al. Oxidant stress in mitochondrial DNA damage, autophagy and inflammation in atherosclerosis. Sci. Rep. 3, 1077 (2013).
35. Martinet, W. & De Meyer, G. R. Autophagy in atherosclerosis: a cell survival and death phenomenon with therapeutic potential. Circ. Res. 104, 304-317 (2009).
36. Levine, B. & Yuan, J. Autophagy in cell death: an innocent convict? J. Clin. Invest. 115, 2679-2688 (2005). (Pubitemid 41434392)
37. Schrijvers, D. M., DeMeyer, G. R. & Martinet, W. Autophagy in atherosclerosis: a potential drug target for plaque stabilization. Arterioscler. Thromb. Vasc. Biol. 31, 2787-2791 (2011).
38. Barlow, A.D., Nicholson, M. L. & Herbert, T. P. Evidence for rapamycin toxicity in pancreatic beta-cells and a review of the underlying molecular mechanisms. Diabetes 62, 2674-2682 (2013).
39. Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M. & Altman, D. G. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS. Biol. 8, e1000412 (2010).
40. Jaffe, E. A., Nachman, R. L., Becker, C. G. & Minick, C. R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 52, 2745-2756 (1973).